Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Nephrology
Clinical Trials: Kidney Transplantation
A listing of clinical trials currently looking for volunteers to enroll in Kidney Transplantation studies. Click on the closest city to find more detailed information on a research study in your area.
California
San Francisco : UCSF Immune Tolerance Network
Study of Kidney Transplant Recipients and Their Donors
View More »
Los Angeles : Cedars-Sinai medical center
Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection
Georgia
Atlanta : Emory Healthcare - Emory University Hospital (EUH)
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
Kentucky
Nebraska
Omaha : University of Nebraska Medical Center
Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation
South Carolina
Charleston : The Medical University of South Carolina
Sirolimus Conversions in African-American Renal Transplant Recipients
Wisconsin
Madison : University of Wisconsin
Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients
Austria
Innsbruck : 1141
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Linz : 1142
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Vienna : 1140
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Vienna : Vienna General Hospital (AKH)/11
A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time
Vienna :
Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®
Belarus
Minsk : 3240
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Belgium
Anderlecht : Pfizer Investigational Site Updated
Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients
Brussels :
Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®
Ghent : University Hospital Ghent
Individually Adapted Immunosuppression in de Novo Renal Transplantation Based on Immune Function Monitoring: a Prospective Randomised Study
Leuven : K.U.Leuven/22
A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time
Canada
Calgary : Foothills Medical Centre
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
Edmonton : University of Alberta Hospital
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
Halifax : Capital District Health Authority
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
Hamilton : St. Joseph's Healthcare
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
London : London Health Sciences Centre
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
View More »
Montreal : Hôpital Maisonneuve-Rosemont
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
Montreal : Hôpital Notre-Dame du CHUM
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
Montreal : McGill University Health Centre
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
Quebec : Centre Hospitalier Universitaire de Québec
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
Saskatoon : St. Paul's Hospital
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
Sherbrooke : Centre Hospitalier Universitaire de Sherbrooke (CHUS)-Hopital Fleurimont
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
Toronto : St. Michael's Hospital
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
Winnipeg : Health Sciences Centre
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
Czech Republic
Brno : Site 1441
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Ostrava - Poruba : 1440
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Prague : University Hospital Motol/61
A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time
Denmark
Aarhus N : Dept. of Renal Medicine, Aarhus University Hospital, Skejby
Context - Remote Ischemic Conditioning in Renal Transplantation - Effect on Immediate and Extended Kidney Graft Function
France
Amiens Cedex : 1752
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Brest Cedex 2 : 1740
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Bron :
Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®
Clermont-Ferrand Cedex 1 : 1742
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Creteil Cedex : 1746
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
View More »
Dijon : 1750
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Le Kremilin Bicetre Cedex : 1741
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Paris :
Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®
Paris Cedex 15 : 1749
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Paris Cedex 15 : Pfizer Investigational Site Updated
Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients
Toulouse Cedex 9 : 1751
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Tours cedex 9 : 1748
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Vandoeuvre Les Nancy : Pfizer Investigational Site Updated
Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients
Vandoeuvre Les Nancy Cedex : 1745
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Germany
Berlin : Pfizer Investigational Site Updated
Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients
Berlin : Universitätsklinikum Charité
Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen
Bochum : 1541
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Erlangen : 1542
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Essen : 1543
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
View More »
Frankfurt : 1544
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Giessen : Department of Internal Medicine, University of Giessen
Impact of Rituximab Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation
Hann.Munden : 1545
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Heidelberg : Site 30
A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients
Heidelberg : 1546
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Heidelberg : Site 30
A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation
Heidelberg :
Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®
Kiel : 1547
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Leipzig : 1548
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Munchen : 1549
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Munster : 1550
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Hungary
Budapest : 1941
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Budapest :
ORANGE Study: An Observational Study on Renal Function in Kidney Transplant Patients on Immunosuppressive Therapy Containing CellCept (Mycophenolate Mofetil)
Italy
Ancona : Novartis Investigative Site
Everolimus in de Novo Kidney Transplant Recipients
Bergamo : Ospedali Riuniti di Bergamo/51
A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time
Bologna : Novartis Investigative Site
Everolimus in de Novo Kidney Transplant Recipients
Brescia : Novartis Investigative Site
Everolimus in de Novo Kidney Transplant Recipients
Cagliari : Novartis Investigative Site
Everolimus in de Novo Kidney Transplant Recipients
View More »
Coppito : Novartis Investigative Site
Everolimus in de Novo Kidney Transplant Recipients
Firenze : Novartis Investigative Site
Everolimus in de Novo Kidney Transplant Recipients
Milano : Novartis Investigative Site
Everolimus in de Novo Kidney Transplant Recipients
Modena : Novartis Investigative Site
Everolimus in de Novo Kidney Transplant Recipients
Novara : Novartis Investigative Site
Everolimus in de Novo Kidney Transplant Recipients
Padova : Novartis Investigative Site
Everolimus in de Novo Kidney Transplant Recipients
Palermo : 2144
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Palermo : Novartis Investigative Site
Everolimus in de Novo Kidney Transplant Recipients
Pavia : Novartis Investigative Site
Everolimus in de Novo Kidney Transplant Recipients
Reggio Calabria : Novartis Investigative Site
Everolimus in de Novo Kidney Transplant Recipients
Roma : 2143
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Roma : Novartis Investigative Site
Everolimus in de Novo Kidney Transplant Recipients
Salerno : Novartis Investigative Site
Everolimus in de Novo Kidney Transplant Recipients
Siena : 2140
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Siena : Novartis Investigative Site
Everolimus in de Novo Kidney Transplant Recipients
Verona : Novartis Investigative Site
Everolimus in de Novo Kidney Transplant Recipients
Japan
Tokyo : Novartis Pharmaceuticals, Japan
Concentration Controlled Everolimus With Reduced Dose Neoral® Versus Mycophenolate Mofetil With Standard Dose Neoral® in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids
Malaysia
Cheras : Hospital Universiti Kebangsaan Malaysia
Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms
Kota Bharu : Hospital Raja Perempuan Zainab II
Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms
Kota Kinabalu : Hospital Queen Elizabeth
Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms
Kuala Lumpur : Hospital Kuala Lumpur
Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms
Kuantan : Hospital Tengku Ampuan Afzan
Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms
View More »
Kuching : Hospital Umum Sarawak
Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms
Pulau Pinang : Hospital Pulau Pinang
Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms
Selayang : Hospital Selayang
Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms
Serdang : Hospital Serdang
Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms
Netherlands
Maastricht : 2240
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Nijmegen : Radboud University Nijmegen Medical Centre
Rituximab for Prevention of Rejection After Renal Transplantation
Poland
Bydgoszcz : Klinika Transplantologii, Szpital Uniwersytecki, ul. M. Sklodowskiej-Curie 9
Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation
Lodz : 2640
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Poznan : 2641
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Warsaw : Site 50
A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients
Warsaw : Children's Memorial Health Institute/71
A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time
View More »
Warsaw : Children's Memorial Health Institute/72
A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time
Warsaw : Site 50
A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation
Warsaw :
Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®
Russian Federation
Kemerovo : 2841
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Moscow : 2843
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Omsk : 2842
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Vol'ginskiy : 2840
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Spain
Alicante : 1640
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Barcelona : 1641
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Madrid : Site 21
A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients
Madrid : Site 22
A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients
Madrid : Site 21
A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation
View More »
Madrid : Site 22
A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation
Santander : 1643
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Vizcaya : 1642
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Sweden
Gothenburg : Sahlgrenska Transplant Institute, Sahlgrenska Academy at the University of Gothenborg
Context - Remote Ischemic Conditioning in Renal Transplantation - Effect on Immediate and Extended Kidney Graft Function
United Kingdom
Birmingham : University Hospital Birmingham
Study of Rituximab to Treat Chronic Renal Transplant Rejection
Birmingham :
Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®
Cambridge : Addenbrooke's Hospital NHS Trust
Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy
Cardiff : University Hospital of Wales
Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy
Cardiff : Univeristy Hospital of Wales
Study of Rituximab to Treat Chronic Renal Transplant Rejection
View More »
Edinburgh : Royal Infirmary
Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy
Glasgow : Western Infirmary
Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy
Hull : Hull Royal Infirmary
Study of Rituximab to Treat Chronic Renal Transplant Rejection
Leeds : Leeds Teaching Hospitals NHS Trust
Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy
Leeds : St Jame's University Hospital
Study of Rituximab to Treat Chronic Renal Transplant Rejection
Liverpool : Royal Liverpool and Broadgreen University Hospitals NHS Trust
Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy
London : Guy's and St Thomas's NHS Trust
Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy
London : Imperial College London and West London Renal & Transplantation Centre
Study of Rituximab to Treat Chronic Renal Transplant Rejection
London : The Royal Free Hospital
Study of Rituximab to Treat Chronic Renal Transplant Rejection
London : King's College London, Guy's Hospital
Study of Rituximab to Treat Chronic Renal Transplant Rejection
Manchester : Site 13
A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients
Manchester : Royal Manchester Children's Hospital/42
A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time
Manchester : Site 13
A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation
Manchester : Central Manchester NHS Trust
Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy
Manchester : Manchester Royal Infirmary
Study of Rituximab to Treat Chronic Renal Transplant Rejection
Manchester :
Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®
Nottingham : Nottingham University Hospitals NHS Trust
Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy
Oxford : Oxford Radcliffe Hospitals NHS Trust
Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy
Plymouth : Plymouth Teaching Hospitals NHS Trust
Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy
Portsmouth : Portsmouth Hospitals NHS Trust
Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy
Sheffield : Sheffield Teaching Hospitals NHS Trust
Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy